glp3 peptide vs glp 1 GLP-1 GLP-3: What's Real, What's Confused What GLP‑3 Really Is: Retatrutide
Description
Singh S, Wright EE Jr, Kwan AY, Thompson JC, Syed IA, Korol EE, et al
Starting mid-2026, Medicare will cover injectable weight-loss medications including Ozempic, Wegovy, Mounjaro, and Zepbound for eligible individuals with severe obesity or related health conditions, at a cost of $245 per month to Medicare and a maximum $50 monthly copay for recipients
Trends Endocrinol
The absence of extensive study on this particular side effect does not invalidate the experiences of those who do experience changes in their facial skin condition while using Ozempic
GLP-2, in comparison, promotes intestinal epithelial proliferation, decreases inflammation and apoptosis, and enhances gut barrier function
Sing et al, 2024)
